ImportRefusal LogoImportRefusal

HALEON

⚠️ High Risk

FEI: 3024306869 • Mississauga, Ontario • CANADA

FEI

FEI Number

3024306869

📍

Location

Mississauga, Ontario

🇨🇦

Country

CANADA
🏢

Address

55 Standish Crt, , Mississauga, Ontario, Canada

High Risk

FDA Import Risk Assessment

53.0
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

4
Total Refusals
6
Unique Violations
10/29/2025
Latest Refusal
11/13/2024
Earliest Refusal

Score Breakdown

Violation Severity
55.0×40%
Refusal Volume
25.9×30%
Recency
96.0×20%
Frequency
40.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

1184×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32803×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

752×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

3361×

INCONSPICU

Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

4831×

DRUG NAME

The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.

Refusal History

DateProductViolationsDivision
10/29/2025
62UCL11DEXTROMETHORPHAN HYDROBROMIDE (ANTI-TUSSIVE/COLD)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Division of Northern Border Imports (DNBI)
10/3/2025
63RBY06STANNOUS FLUORIDE (DENTAL CARIES PROPHYLACTIC)
118NOT LISTED
3280FRNMFGREG
336INCONSPICU
483DRUG NAME
75UNAPPROVED
Division of Northern Border Imports (DNBI)
6/4/2025
60LAA01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
3280FRNMFGREG
Division of Southeast Imports (DSEI)
11/13/2024
60LAY01ACETAMINOPHEN (ANALGESIC)
118NOT LISTED
473LABELING
Division of Northern Border Imports (DNBI)

Frequently Asked Questions

What is HALEON's FDA import refusal history?

HALEON (FEI: 3024306869) has 4 FDA import refusal record(s) in our database, spanning from 11/13/2024 to 10/29/2025.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. HALEON's FEI number is 3024306869.

What types of violations has HALEON received?

HALEON has been cited for 6 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about HALEON come from?

All FDA import refusal data for HALEON is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.